<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ILEX ONCOLOGY, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 74-2699185
- --------------------------------------- ------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
11550 IH-10 West, Suite 300
San Antonio, TX 78230
- ----------------------- -------------
(Address of principal executive offices) (Zip Code)
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
- ------------------- -------------------------------------
Not Applicable Not Applicable
If this Form relates to the registration of a class of debt securities
and is effective upon filing pursuant to General Instruction A.(c)(1), please
check the following box.[ ]
If this Form relates to the registration of a class of debt securities
and is to become effective simultaneously with the effectiveness of a
concurrent registration statement under the Securities Act of 1933 pursuant to
General Instruction A.(c)(2), please check the following box.[ ]
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
Common Stock, par value $.01 per share
(Title of Class)
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered
The securities to be registered are shares of common stock, $.01
par value (the "Common Stock"), of the Registrant. A description of the Common
Stock is set forth under the caption "Description of Capital Stock" in the
preliminary prospectus, subject to completion, dated January 31, 1997, which
constitutes part of the Registrant's Registration Statement on Form S-1, as
amended (Reg. No. 333-17769), under the Securities Act of 1933, as amended (the
"Act"), which description is incorporated herein by reference. Such
description will be included in a form of prospectus to be filed by the
Registrant pursuant to Rule 424(b) under the Act, which prospectus shall be
deemed to be incorporated herein by reference.
Item 2. Exhibits
1. Amended and Restated Certificate of Incorporation of the
Registrant (incorporated herein by reference to Exhibit
3.1 of the Registration Statement on Form S-1 (Reg. No.
333-17769)).
2. Bylaws of the Registrant (incorporated herein by reference
to Exhibit 3.2 of the Registration Statement on Form S-1
(Reg. No. 333-17769)).
3. Specimen Common Stock Certificate of the Registrant
(incorporated herein by reference to Exhibit 4.1 of the
Registration Statement on Form S-1 (Reg. No. 333-17769)).
-2-
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the Registrant has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized.
ILEX ONCOLOGY, INC.
By:/s/ Richard L. Love
------------------------------------------
Richard L. Love
President and Chief Executive Officer
(principal executive officer)
Dated: February 14, 1997
-3-
